Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

about

CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation.Cancer metabolism gets physical.Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer Advanced model systems and tools for basic and translational human immunology

P2860

Q47443248-B960F8F1-FD1B-4558-B63E-21ABE40B33AD Q55021535-D9E86E4F-7DF0-4A98-9B15-3418131E0B93 Q58737053-EF7930E3-9F8B-4306-8C6B-D90357C9937F Q59126043-26C18926-2E53-4A3B-BFF9-49DE3C8B47F6

P2860

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Item

http://www.wikidata.org/entity/Q47382765

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@en

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@nl

type

Item

label

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@en

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@nl

prefLabel

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@en

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

@nl

P1476

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

@en

P2093

Adriano Piris

http://www.w3.org/2001/XMLSchema#string

Alicia Smart

http://www.w3.org/2001/XMLSchema#string

Amir R Aref

http://www.w3.org/2001/XMLSchema#string

Anat O Stemmer-Rachamimov

http://www.w3.org/2001/XMLSchema#string

Andrew Portell

http://www.w3.org/2001/XMLSchema#string

Asaf Rotem

http://www.w3.org/2001/XMLSchema#string

Ashley Merlino

http://www.w3.org/2001/XMLSchema#string

Bart Phillips

http://www.w3.org/2001/XMLSchema#string

Benchun Miao

http://www.w3.org/2001/XMLSchema#string

Benjamin Izar

http://www.w3.org/2001/XMLSchema#string

P2860

CCR7 and its ligands: balancing immunity and tolerance

Precision medicine for cancer with next-generation functional diagnostics

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

The blockade of immune checkpoints in cancer immunotherapy

Immune checkpoint blockade: a common denominator approach to cancer therapy

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Screening therapeutic EMT blocking agents in a three-dimensional microenvironment

P304

196-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-17-0833

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29101162

http://www.w3.org/2001/XMLSchema#string

P932

5809290

http://www.w3.org/2001/XMLSchema#string

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

about

P2860

P2860

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932